Predictors of mortality after acute hip fracture

被引:52
作者
Nettleman, MD
Alsip, J
Schrader, M
Schulte, M
机构
[1] Division of General Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA
[2] Iowa Foundation for Medical Care, West Des Moines, IA
[3] Department of Internal Medicine, MCV/VCU, Richmond, VA 23298-0102
关键词
hip fracture; mortality; outcome; aspirin;
D O I
10.1007/BF02598997
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To identify determinants of mortality after hip fracture, we performed a multicenter, retrospective study of 390 Medicare beneficiaries. Independent predictors of 30-day mortality included a history of congestive heart failure (odds ratio [OR] 32; 95% confidence interval [CI] 5, 192), angina (OR 26; 95% CI 4, 184), or chronic pulmonary disease (OR 11; 95% CI 2, 62). Postoperative use of aspirin was associated with a reduced risk of mortality (OR 0.24; 95% CI 0.08, 0.70). Cardiovascular events were the presumed cause of 63% of in-hospital deaths. Aspirin may have significant potential to reduce mortality in this population and deserves further study.
引用
收藏
页码:765 / 767
页数:3
相关论文
共 20 条
  • [1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [2] PHYSICIAN PRACTICES IN THE PREVENTION OF VENOUS THROMBOEMBOLISM
    ANDERSON, FA
    WHEELER, HB
    GOLDBERG, RJ
    HOSMER, DW
    FORCIER, A
    PATWARDHAN, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 591 - 595
  • [3] [Anonymous], 1994, BMJ
  • [4] PREVENTION OF VENOUS THROMBOEMBOLISM
    CLAGETT, GP
    ANDERSON, FA
    HEIT, J
    LEVINE, MN
    WHEELER, HB
    [J]. CHEST, 1995, 108 (04) : S312 - S334
  • [5] REDUCTION IN FATAL PULMONARY-EMBOLISM AND VENOUS THROMBOSIS BY PERIOPERATIVE ADMINISTRATION OF SUBCUTANEOUS HEPARIN - OVERVIEW OF RESULTS OF RANDOMIZED TRIALS IN GENERAL, ORTHOPEDIC, AND UROLOGIC SURGERY
    COLLINS, R
    SCRIMGEOUR, A
    YUSUF, S
    PETO, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) : 1162 - 1173
  • [6] HIP-FRACTURES IN THE ELDERLY - A WORLDWIDE PROJECTION
    COOPER, C
    CAMPION, G
    MELTON, LJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 1992, 2 (06) : 285 - 289
  • [7] FITZGERALD JF, 1987, JAMA-J AM MED ASSOC, V258, P218
  • [8] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) : 129 - 135
  • [9] A METAANALYSIS OF METHODS TO PREVENT VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT
    IMPERIALE, TF
    SPEROFF, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (22): : 1780 - 1785
  • [10] THE HEALTH-CARE QUALITY IMPROVEMENT INITIATIVE - A NEW APPROACH TO QUALITY ASSURANCE IN MEDICARE
    JENCKS, SF
    WILENSKY, GR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07): : 900 - 903